The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Gallbladder cancer: epidemiology and outcome
Open accessAbstract
Gallbladder cancer, though generally considered rare, is the most common malignancy of the biliary tract, accounting for 80%-95% of biliary tract cancers. An early diagnosis is essential as this malignancy progresses silently with a late diagnosis, often proving fatal. Its carcinogenesis follows a progression through a metaplasia-dysplasia-carcinoma sequence. This comprehensive review focuses on and explores the risks, management, and outcomes for primary gallbladder carcinoma. Epidemiological studies have identified striking geographic and ethnic disparities - inordinately high occurrence in American Indians, elevated in Southeast Asia, yet quite low elsewhere in the Americas and the world. Age, female sex, congenital biliary tract anomalies, and a genetic predisposition represent important risk factors that are immutable. Environmental triggers play a critical role in eliciting cancer developing in the gallbladder, best exemplified by cholelithiasis and chronic inflammation from biliary tract and parasitic infections. Mortality rates closely follow incidence; those countries with the highest prevalence of gallstones experience the greatest mortality from gallbladder cancer. Vague symptoms often delay the diagnosis of gallbladder cancer, contributing to its overall progression and poor outcome. Surgery represents the only potential for cure. Some individuals are fortunate to be incidentally found to have gallbladder cancer at the time of cholecystectomy being performed for cholelithiasis. Such an early diagnosis is imperative as a late presentation connotes advanced staging, nodal involvement, and possible recurrence following attempted resection. Overall mean survival is a mere 6 months, while 5-year survival rate is only 5%. The dismal prognosis, in part, relates to the gallbladder lacking a serosal layer adjacent to the liver, enabling hepatic invasion and metastatic progression. Improved imaging modalities are helping to diagnose patients at an earlier stage. The last decade has witnessed improved outcomes as aggressive surgical management and preoperative adjuvant therapy has helped prolong survival in patients with gallbladder cancer. In the future, the development of potential diagnostic markers for disease will yield screening opportunities for those at risk either with ethnic susceptibility or known anatomic anomalies of the biliary tract. Meanwhile, clarification of the value of prophylactic cholecystectomy should provide an opportunity for secondary prevention. Primary prevention will arrive once the predictive biomarkers and environmental risk factors are more clearly identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
Stinton, L. M., & Shaffer, E. A. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.172 · Cited by 1,381
Self-citationDiagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Gallbladder cancer worldwide: Geographical distribution and risk factors
Randi, G., Franceschi, S., & La Vecchia, C. (2006) · International Journal of Cancer · doi:10.1002/ijc.21683 · Cited by 941
Epidemiology and Molecular Pathology of Gallbladder Cancer
Lazcano-Ponce, E. C., Miquel, J. F., Munoz, N., Herrero, R., Ferrecio, C., Wistuba, I. I., Alonso de Ruiz, P., Aristi Urista, G., & Nervi, F. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.6.349 · Cited by 866
Epidemiology of gallbladder stone disease
Shaffer, E. A. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.05.004 · Cited by 799
Self-citationWolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)
Duffy, A., Capanu, M., Abou‐Alfa, G. K., Huitzil, D., Jarnagin, W., Fong, Y., D'Angelica, M., DeMatteo, R. P., Blumgart, L. H., & O'Reilly, E. M. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21141 · Cited by 473
Gallbladder cancer: lessons from a rare tumour
Wistuba, I. I., & Gazdar, A. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1429 · Cited by 454
Lung Cancer in Radon-Exposed Miners and Estimation of Risk From Indoor Exposure
Lubin, J. H., Boice, J. D., Edling, C., Hornung, R. W., Howe, G. R., Kunz, E., Kusiak, R. A., Morrison, H. I., Radford, E. P., Samet, J. M., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.817 · Cited by 399
Sampliner, R. E., Bennett, P. H., Comess, L. J., Rose, F. A., & Burch, T. A. (1970) · New England Journal of Medicine · doi:10.1056/nejm197012172832502 · Cited by 390
Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state
Gonzalez-Escobedo, G., Marshall, J. M., & Gunn, J. S. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2490 · Cited by 332
Cancer surveillance in patients with primary sclerosing cholangitis
Razumilava, N., Gores, G. J., & Lindor, K. D. (2011) · Hepatology · doi:10.1002/hep.24570 · Cited by 292
Corvera, C. U., Blumgart, L. H., Akhurst, T., DeMatteo, R. P., D’Angelica, M., Fong, Y., & Jarnagin, W. R. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.002 · Cited by 292
Carcinoma in the porcelain gallbladder: A relationship revisited
Stephen, A. E., & Berger, D. L. (2001) · Surgery · doi:10.1067/msy.2001.113888 · Cited by 290
Zatonski, W. A., Przewozniak, K., Lowenfels, A. B., Boyle, P., Maisonneuve, P., Bueno de Mesquita, H. B., Moerman, C. J., Ghadirian, P., Simard, A., Jain, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1132 · Cited by 286
Gallstone Size and the Risk of Gallbladder Cancer
Diehl, A. K. (1983) · JAMA · doi:10.1001/jama.1983.03340170049027 · Cited by 274
Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris
Miquel, J. F., Covarrubias, C., Villaroel, L., Mingrone, G., Greco, A. V., Puglielli, L., Carvallo, P., Marshall, G., Pino, G. D., & Nervi, F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70266-5 · Cited by 237
Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy
Sheth, S., Bedford, A., & Chopra, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00862-5 · Cited by 229
Diagnosis and Surgical Management of Gallbladder Cancer: A Review
Reid, K. M., la Medina, A. R., & Donohue, J. H. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0075-x · Cited by 225
Terzi, C., Sökmen, S., Seçkın, S., Albayrak, L., & UĞurlu, M. (2000) · Surgery · doi:10.1067/msy.2000.105870 · Cited by 216
Jørgensen, T., & Jensen, K. H. (1990) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1990.12067104 · Cited by 206
Gallbladder Polyps: Epidemiology, Natural History and Management
Myers, R. P., Shaffer, E. A., & Beck, P. L. (2002) · Canadian Journal of Gastroenterology · doi:10.1155/2002/787598 · Cited by 204
Self-citationGallbladder cancer: a morphological and molecular update
Goldin, R. D., & Roa, J. C. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03192.x · Cited by 197
Obesity and the risk of gallbladder cancer: a meta-analysis
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603703 · Cited by 190
Lewis, J. T., Talwalkar, J. A., Rosen, C. B., Smyrk, T. C., & Abraham, S. C. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213435.99492.8a · Cited by 187
Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients
Ouchi, K., Mikuni, J., & Not Available, Y. K. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200028 · Cited by 187
Gallstone Growth, Size, and Risk of Gallbladder Cancer: An Interracial Study
LOWENFELS, A. B., WALKER, A. M., ALTHAUS, D. P., TOWNSEND, G., & DOMELLÖF, L. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.50 · Cited by 181
Pignochino, Y., Sarotto, I., Peraldo-Neia, C., Penachioni, J. Y., Cavalloni, G., Migliardi, G., Casorzo, L., Chiorino, G., Risio, M., Bardelli, A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-631 · Cited by 173
Diagnosis and Management of Gallbladder Polyps
Andrén‐Sandberg, Å. (2012) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.95897 · Cited by 165
Everhart, J. E., Yeh, F., Lee, E. T., Hill, M. C., Fabsitz, R., Howard, B. V., & Welty, T. K. (2002) · Hepatology · doi:10.1053/jhep.2002.33336 · Cited by 164
Gallbladder cancer: Can newer insights improve the outcome?
Dutta, U. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07048.x · Cited by 134
Infection as a risk factor for gallbladder cancer
Kumar, S., Kumar, S., & Kumar, S. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20530 · Cited by 121
Carcinoma in the Porcelain Gallbladder
Berk, R. N., Armbuster, T. G., & Saltzstein, S. L. (1973) · Radiology · doi:10.1148/106.1.29 · Cited by 117
Epidemiology of gallstone disease in Chandigarh: A community‐based study
Singh, V., Trikha, B., Nain, C., Singh, K., & Bose, S. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02484.x · Cited by 89
Hyder, O. N., Dodson, R. M., Sachs, T. E., Weiss, M. J., Mayo, S. C., Choti, M. A., Wolfgang, C. L., Herman, J. M., & Pawlik, T. M. (2013) · Surgery · doi:10.1016/j.surg.2013.06.001 · Cited by 47
Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy?
Le, M. D., Henson, D. E., Young, H. A., & Albores‐Saavedra, J. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31542-x · Cited by 32
Cited by
Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update
Sharma, A., Sharma, K. L., Gupta, A., Yadav, A., & Kumar, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.3978 · Cited by 424
Roa, J. C., García, P., Kapoor, V. K., Maithel, S. K., Javle, M., & Koshiol, J. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00398-y · Cited by 401
Epidemiology of gallbladder cancer
Rawla, P., Sunkara, T., Thandra, K. C., & Barsouk, A. (2019) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2019.85166 · Cited by 354
The Oral Microbiome and Cancer
Irfan, M., Delgado, R. Z. R., & Frias-Lopez, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591088 · Cited by 341
Updated epidemiology of gastrointestinal cancers in East Asia
Huang, J., Lucero-Prisno, D. E., Zhang, L., Xu, W., Wong, S. H., Ng, S. C., & Wong, M. C. S. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00726-3 · Cited by 269
Metadata
- Authors
- Shaffer, E., & Hundal, R.
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2014-03
- Volume
- 6
- Pages
- 99
- ISSN
- 1179-1349 (ISSN-L)
- OpenAlex
- W2087350855
- Cited by
- 1,089
- References
- 44
- FWCI
- 46.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.